Experimental Study on the Targeting Ability of Folate-conjugated Penicillin G Amidase to SKOV3 Solid Tumors

YANG Ke-ya,FU Shen,FAN Wo,ZHANG You-jiu,XU Yu-jie,ZHU Ran,WANG Dao-jin,HU Ming-jiang,ZHANG Qi,XIANG Guang-ya

DOI: https://doi.org/10.3969/j.issn.1000-7512.2007.04.004

2007-01-01

Abstract:By isotope tracer technique,experiments of SPECT and biodistribution on nude mice bearing tumor are performed to explore whether folate-conjugated penicillin G amidase(F-PGA) has the ability of targeting to folate receptor positive solid tumors,which will be helpful to establish a base for further targeting therapies.The results showed that the labeling efficiencies of 125I-F-PGA and 125I-PGA are 90%,and their radiochemical purities are more than 95% after purified,with suitable stabilities both in vivo and in vitro.At 4~24 h postinjection,the appreciable radioactivity accumulation at tumor position can be obtained from SPECT images of 125I-F-PGA administered group,however which is not seen in the contrast group of 125I-PGA at any time.The radioactivity ratio of tumor to muscle(T/M) of 125I-F-PGA is obviously higher than that of the contrast(F=13.38,P=0.014 6).125I-F-PGA is quickly cleared from non-targeted sites.It indicated that by folate receptor pathway,F-PGA can specially target to folate receptor positive SKOV3 solid tumors in vivo,with good feature of target to non-target tissues,and it may be an ideal agent for targeting therapies.